Showing articles with keyword: Indiana University | CLEAR

Chandan Sen
August 15, 2018

CTSI Welcomes New Associate Director for Technology and Innovation

The Indiana Clinical and Translational Sciences Institute’s (CTSI) expert leadership team is growing, mostly recently with the addition of prolific regenerative medicine researcher Chandan Sen, PhD.
Chandan Sen, PhD (Photo by IU School of Medicine)
Dr. Sen was recently recruited to IU School of Medicine from The Ohio State University. At IU, he will serve as inaugural director of the Indiana Center for Regenerative Medicine and Engineering effective August 15. Dr. Sen brings with him more than $10 million in research grants and a team of more than 30 scientists and staff who will study how to tap into the power of regenerative...

August 15, 2018

CTSI to Provide Support for Researchers’ Use of New Mobile Study Tool

Are you a researcher looking to further streamline your study’s design and collect more objective and multi-dimensional data from study participants?
The Indiana Clinical and Translational Sciences Institute (CTSI) has opened a new RFA for funding to use a new research tool from the Indiana Biosciences Research Institute (IBRI) and MavenSphere Inc. called DigiBiomarkers.
DigiBiomarkers is a HIPAA-compliant, cloud-based mobile and web application platform for researchers that aims to collect real-time, continuous and objective digital data from study participants. The platform provides a user-friendly clinical study management tool kit that researchers can use to customize their studies. DigiBiomarkers also automates a...

Ryan Ballard
August 15, 2018

We Can Help: NIH Single Institutional Review Board Policy for Multi-Site Research

NIH funding deadlines are coming up, so it’s important to make sure you’re aware of new research policy guidelines.
Indiana CTSI and IU Human Subjects Office staff (left to right): Christine Caldwell, Ryan Ballard and Amy Waltz.
Applications for human subjects research that will conduct the same protocol at multiple institutions must include a plan for compliance with the Final NIH Policy on the Use of a Single Institutional Review Board (IRB) for Multi-Site Research.
The policy requires a single IRB to provide review for all sites.
If you are working on a grant application that is subject to the policy, please contact Indiana...

CTSI Annual Meeting 2017
August 2, 2018

Indiana CTSI Annual Meeting to Celebrate 10 Years, Focus on Gene Therapy Research

Faculty and staff researchers, students and the public are invited to celebrate the 10th anniversary of the Indiana Clinical and Translational Sciences Institute (CTSI) at its 2018 Annual Meeting on Friday, September 14, at Hine Hall on the IUPUI campus in Indianapolis.
Researchers present posters at the Indiana CTSI’s 2017 Annual Meeting.
Founded in 2008, the Indiana CTSI brings together the state’s brightest minds to solve Indiana’s most pressing health challenges through research. The institute is a statewide partnership among Indiana University, Purdue University, the University of Notre Dame and numerous life sciences businesses, government entities and community organizations.
This year’s Annual...

August 2, 2018

Indiana CTSI to Host Mock Study Section at National Translational Science Conference

By Ashlynn Neumeyer: 
The Indiana Clinical and Translational Sciences Institute (CTSI) will host the Association for Clinical and Translational Sciences (ACTS) Mock Study Section for the next three years, debuting in March 2019. The goal of the ACTS meeting is to support and advance translational science, or the translation of research and discoveries in the lab into therapies and solutions that improve human health.
The Mock Study Section is a formal workshop that replicates for participants the review process for how the National Institutes of Health (NIH) decides which grant applications will be funded. During the event, scientific review officers and...

Milan Radovich
June 27, 2018

Research by CTSI-Supported Investigator Has Led to First-in-Human Clinical Trial

Milan Radovich, PhD
Early research by Indiana University School of Medicine’s Milan Radovich, PhD, whose work was supported by the Indiana CTSI, has led to the launch of a first-in-human clinical trial that aims to treat an aggressive type of breast cancer.
Dr. Radovich, who is now an assistant professor in the IU School of Medicine’s Department of Surgery, received a Pre-doctoral (TL1) Award from the Indiana CTSI in 2010-2011 for his research project titled “Novel targets in triple negative breast cancer.”
He says that research has informed the clinical trial going on now, which is using precision medicine to target multiple genetic culprits...

Anna Roberts, data navigator
June 20, 2018

Meet Anna Roberts, the Indiana CTSI’s Data Navigator

By Ashlynn Neumeyer:
Anna Roberts is the new data navigator for the Indiana Clinical and Translational Sciences Institute (CTSI), where she serves as a resource for investigators across Indiana University, Purdue University and the University of Notre Dame who are looking to harness data expertise available through the Regenstrief Institute. Roberts succeeds Faye Smith, who is now Director of Research Services at Regenstrief.
Anna Roberts (Regenstrief Institute photo)
As data navigator and assistant manager of Regenstrief’s Data Core, which is a designated core of the Indiana CSTI, Roberts is responsible for responding to researchers’ requests for information, meeting with new investigators to...

Tiffany Campbell
May 22, 2018

Indiana CTSI Receives $33M NIH Grant to Improve Health Statewide, with Public’s Participation

Indiana consistently lands near the bottom of the nation’s health ranking lists, with too many babies dying before their first birthday and too many people smoking and abusing drugs.
The Indiana CTSI is a statewide research partnership among Indiana University, Purdue University and the University of Notre Dame, represented by the institute’s three-color logo.
A statewide network of researchers and staff at Indiana University, Purdue University and the University of Notre Dame have been working together to reverse this poor state of health, and are now seeking the help of Indiana residents of all ages and backgrounds as their partners.
Indiana’s preeminent...

Smith, Ekser and Li
May 11, 2018

IU Researchers Using CTSI 3D Bioprinting Core to Study Organs

Indiana University School of Medicine scientist and transplant surgeon Burcin Ekser, MD, PhD, will boost his lab’s xenotransplantation, or cross-species transplantation, research program with a four-year, $9 million research agreement with Lung Biotechnology PBC.
IU School of Medicine researchers Lester Smith, PhD; Burcin Ekser, MD, PhD; and Ping Li, PhD. (Photo courtesy of IU School of Medicine)
According to the latest data from the Organ Procurement and Transplantation Network, there are more than 110,000 people in the United States waiting for a life-saving organ transplant, and each day, about 20 people die while waiting for a transplant.
Dr. Ekser and his team are working...

Anantha Shekhar speaks at CTSI IU Bloomington Retreat
April 27, 2018

View Presentations from CTSI Opioid Conference

Anantha Shekhar, MD, PhD, director of the Indiana CTSI, speaks at the CTSI’s opioid conference April 25 at IU Bloomington.
Scientists, policy-makers and community members from across Indiana recently gathered April 25 at the Indiana CTSI’s annual retreat at Indiana University Bloomington to discuss opioid research and evidence-based solutions to the state’s opioid crisis.
Thank you to everyone who attended and helped make our event a success.
Couldn’t make it to the conference? Presentations from our speakers are available below for those who wish to download them.
Indiana CTSI 2018 IU Bloomington Retreat Presentations:

“Indiana and CTSI Initiatives to Address the Opiate Crisis” – Anantha...